Fibroblast Growth Factor 23, Endogenous Erythropoietin, Erythropoiesis-Stimulating Agents, and Erythropoietin Resistance in Hemodialysis Patients
Both intact and C-terminal FGF23 showed similar associations with ESA dose, but they showed different patterns of association with other parameters related to anemia. Further research is needed to elucidate the mechanisms underlying these different associations.
Authors
- Takao Suga
- Hiroo Takahashi (ORCID: https://orcid.org/0000-0003-2425-3451)
- Takehiko Wada (ORCID: https://orcid.org/0000-0001-9740-5183)
- Naoto Hamano (ORCID: https://orcid.org/0000-0001-7105-6843)
- Hirotaka Komaba (ORCID: https://orcid.org/0000-0002-1704-4507)
- Yuichiro Takahashi (ORCID: https://orcid.org/0000-0001-7352-4954)
- Masafumi Fukagawa (ORCID: https://orcid.org/0000-0002-7832-2339)
- Takatoshi Kakuta (ORCID: https://orcid.org/0000-0002-7235-0726)
- Hisae Tanaka
- Miho Hida
- Toru Hyodo
Institutions
- Tokai University (JP)
- Showa Corporation (JP)
- Tokai University Hachioji Hospital (JP)
- Shonan Oiso Hospital (JP)
- Ebina General Hospital (JP)
- Kishokai Medical Corporation (JP)
- Toranomon Hospital (JP)
Publication Details
- Journal
- American Journal of Nephrology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1159/000543506
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43